Global Solid-phase Oligonucleotide Synthesis Market Research Report 2024(Status and Outlook)
Report Overview:
The Global Solid-phase Oligonucleotide Synthesis Market Size was estimated at USD 481.99 million in 2023 and is projected to reach USD 1223.76 million by 2029, exhibiting a CAGR of 16.80% during the forecast period.
This report provides a deep insight into the global Solid-phase Oligonucleotide Synthesis market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Solid-phase Oligonucleotide Synthesis Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Solid-phase Oligonucleotide Synthesis market in any manner.
Global Solid-phase Oligonucleotide Synthesis Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Genescript
GeneArt (Thermofischer)
Renesas Electronics Corporation
DNA 2.0 (ATUM)
OriGene
BBI
Genewiz
Eurofins Genomics
Gene Oracle
SBS Genetech
Bio Basic
Market Segmentation (by Type)
Primers
Probes
Intermediate-scale Synthesis Oligos
Large-scale Synthesis Oligos
Linkers and Adaptors
Market Segmentation (by Application)
Commercial
Academic Research
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Solid-phase Oligonucleotide Synthesis Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Global Solid-phase Oligonucleotide Synthesis Market Size was estimated at USD 481.99 million in 2023 and is projected to reach USD 1223.76 million by 2029, exhibiting a CAGR of 16.80% during the forecast period.
This report provides a deep insight into the global Solid-phase Oligonucleotide Synthesis market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Solid-phase Oligonucleotide Synthesis Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Solid-phase Oligonucleotide Synthesis market in any manner.
Global Solid-phase Oligonucleotide Synthesis Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Genescript
GeneArt (Thermofischer)
Renesas Electronics Corporation
DNA 2.0 (ATUM)
OriGene
BBI
Genewiz
Eurofins Genomics
Gene Oracle
SBS Genetech
Bio Basic
Market Segmentation (by Type)
Primers
Probes
Intermediate-scale Synthesis Oligos
Large-scale Synthesis Oligos
Linkers and Adaptors
Market Segmentation (by Application)
Commercial
Academic Research
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Solid-phase Oligonucleotide Synthesis Market
- Overview of the regional outlook of the Solid-phase Oligonucleotide Synthesis Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Solid-phase Oligonucleotide Synthesis Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Solid-phase Oligonucleotide Synthesis
1.2 Key Market Segments
1.2.1 Solid-phase Oligonucleotide Synthesis Segment by Type
1.2.2 Solid-phase Oligonucleotide Synthesis Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SOLID-PHASE OLIGONUCLEOTIDE SYNTHESIS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Solid-phase Oligonucleotide Synthesis Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Solid-phase Oligonucleotide Synthesis Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SOLID-PHASE OLIGONUCLEOTIDE SYNTHESIS MARKET COMPETITIVE LANDSCAPE
3.1 Global Solid-phase Oligonucleotide Synthesis Sales by Manufacturers (2019-2024)
3.2 Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Manufacturers (2019-2024)
3.3 Solid-phase Oligonucleotide Synthesis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Solid-phase Oligonucleotide Synthesis Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Solid-phase Oligonucleotide Synthesis Sales Sites, Area Served, Product Type
3.6 Solid-phase Oligonucleotide Synthesis Market Competitive Situation and Trends
3.6.1 Solid-phase Oligonucleotide Synthesis Market Concentration Rate
3.6.2 Global 5 and 10 Largest Solid-phase Oligonucleotide Synthesis Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 SOLID-PHASE OLIGONUCLEOTIDE SYNTHESIS INDUSTRY CHAIN ANALYSIS
4.1 Solid-phase Oligonucleotide Synthesis Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF SOLID-PHASE OLIGONUCLEOTIDE SYNTHESIS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 SOLID-PHASE OLIGONUCLEOTIDE SYNTHESIS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Solid-phase Oligonucleotide Synthesis Sales Market Share by Type (2019-2024)
6.3 Global Solid-phase Oligonucleotide Synthesis Market Size Market Share by Type (2019-2024)
6.4 Global Solid-phase Oligonucleotide Synthesis Price by Type (2019-2024)
7 SOLID-PHASE OLIGONUCLEOTIDE SYNTHESIS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Solid-phase Oligonucleotide Synthesis Market Sales by Application (2019-2024)
7.3 Global Solid-phase Oligonucleotide Synthesis Market Size (M USD) by Application (2019-2024)
7.4 Global Solid-phase Oligonucleotide Synthesis Sales Growth Rate by Application (2019-2024)
8 SOLID-PHASE OLIGONUCLEOTIDE SYNTHESIS MARKET SEGMENTATION BY REGION
8.1 Global Solid-phase Oligonucleotide Synthesis Sales by Region
8.1.1 Global Solid-phase Oligonucleotide Synthesis Sales by Region
8.1.2 Global Solid-phase Oligonucleotide Synthesis Sales Market Share by Region
8.2 North America
8.2.1 North America Solid-phase Oligonucleotide Synthesis Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Solid-phase Oligonucleotide Synthesis Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Solid-phase Oligonucleotide Synthesis Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Solid-phase Oligonucleotide Synthesis Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Solid-phase Oligonucleotide Synthesis Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Genescript
9.1.1 Genescript Solid-phase Oligonucleotide Synthesis Basic Information
9.1.2 Genescript Solid-phase Oligonucleotide Synthesis Product Overview
9.1.3 Genescript Solid-phase Oligonucleotide Synthesis Product Market Performance
9.1.4 Genescript Business Overview
9.1.5 Genescript Solid-phase Oligonucleotide Synthesis SWOT Analysis
9.1.6 Genescript Recent Developments
9.2 GeneArt (Thermofischer)
9.2.1 GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Basic Information
9.2.2 GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Product Overview
9.2.3 GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Product Market Performance
9.2.4 GeneArt (Thermofischer) Business Overview
9.2.5 GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis SWOT Analysis
9.2.6 GeneArt (Thermofischer) Recent Developments
9.3 Renesas Electronics Corporation
9.3.1 Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Basic Information
9.3.2 Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Product Overview
9.3.3 Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Product Market Performance
9.3.4 Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis SWOT Analysis
9.3.5 Renesas Electronics Corporation Business Overview
9.3.6 Renesas Electronics Corporation Recent Developments
9.4 DNA 2.0 (ATUM)
9.4.1 DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Basic Information
9.4.2 DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Product Overview
9.4.3 DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Product Market Performance
9.4.4 DNA 2.0 (ATUM) Business Overview
9.4.5 DNA 2.0 (ATUM) Recent Developments
9.5 OriGene
9.5.1 OriGene Solid-phase Oligonucleotide Synthesis Basic Information
9.5.2 OriGene Solid-phase Oligonucleotide Synthesis Product Overview
9.5.3 OriGene Solid-phase Oligonucleotide Synthesis Product Market Performance
9.5.4 OriGene Business Overview
9.5.5 OriGene Recent Developments
9.6 BBI
9.6.1 BBI Solid-phase Oligonucleotide Synthesis Basic Information
9.6.2 BBI Solid-phase Oligonucleotide Synthesis Product Overview
9.6.3 BBI Solid-phase Oligonucleotide Synthesis Product Market Performance
9.6.4 BBI Business Overview
9.6.5 BBI Recent Developments
9.7 Genewiz
9.7.1 Genewiz Solid-phase Oligonucleotide Synthesis Basic Information
9.7.2 Genewiz Solid-phase Oligonucleotide Synthesis Product Overview
9.7.3 Genewiz Solid-phase Oligonucleotide Synthesis Product Market Performance
9.7.4 Genewiz Business Overview
9.7.5 Genewiz Recent Developments
9.8 Eurofins Genomics
9.8.1 Eurofins Genomics Solid-phase Oligonucleotide Synthesis Basic Information
9.8.2 Eurofins Genomics Solid-phase Oligonucleotide Synthesis Product Overview
9.8.3 Eurofins Genomics Solid-phase Oligonucleotide Synthesis Product Market Performance
9.8.4 Eurofins Genomics Business Overview
9.8.5 Eurofins Genomics Recent Developments
9.9 Gene Oracle
9.9.1 Gene Oracle Solid-phase Oligonucleotide Synthesis Basic Information
9.9.2 Gene Oracle Solid-phase Oligonucleotide Synthesis Product Overview
9.9.3 Gene Oracle Solid-phase Oligonucleotide Synthesis Product Market Performance
9.9.4 Gene Oracle Business Overview
9.9.5 Gene Oracle Recent Developments
9.10 SBS Genetech
9.10.1 SBS Genetech Solid-phase Oligonucleotide Synthesis Basic Information
9.10.2 SBS Genetech Solid-phase Oligonucleotide Synthesis Product Overview
9.10.3 SBS Genetech Solid-phase Oligonucleotide Synthesis Product Market Performance
9.10.4 SBS Genetech Business Overview
9.10.5 SBS Genetech Recent Developments
9.11 Bio Basic
9.11.1 Bio Basic Solid-phase Oligonucleotide Synthesis Basic Information
9.11.2 Bio Basic Solid-phase Oligonucleotide Synthesis Product Overview
9.11.3 Bio Basic Solid-phase Oligonucleotide Synthesis Product Market Performance
9.11.4 Bio Basic Business Overview
9.11.5 Bio Basic Recent Developments
10 SOLID-PHASE OLIGONUCLEOTIDE SYNTHESIS MARKET FORECAST BY REGION
10.1 Global Solid-phase Oligonucleotide Synthesis Market Size Forecast
10.2 Global Solid-phase Oligonucleotide Synthesis Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Solid-phase Oligonucleotide Synthesis Market Size Forecast by Country
10.2.3 Asia Pacific Solid-phase Oligonucleotide Synthesis Market Size Forecast by Region
10.2.4 South America Solid-phase Oligonucleotide Synthesis Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Solid-phase Oligonucleotide Synthesis by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Solid-phase Oligonucleotide Synthesis Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Solid-phase Oligonucleotide Synthesis by Type (2025-2030)
11.1.2 Global Solid-phase Oligonucleotide Synthesis Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Solid-phase Oligonucleotide Synthesis by Type (2025-2030)
11.2 Global Solid-phase Oligonucleotide Synthesis Market Forecast by Application (2025-2030)
11.2.1 Global Solid-phase Oligonucleotide Synthesis Sales (K Units) Forecast by Application
11.2.2 Global Solid-phase Oligonucleotide Synthesis Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Solid-phase Oligonucleotide Synthesis
1.2 Key Market Segments
1.2.1 Solid-phase Oligonucleotide Synthesis Segment by Type
1.2.2 Solid-phase Oligonucleotide Synthesis Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SOLID-PHASE OLIGONUCLEOTIDE SYNTHESIS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Solid-phase Oligonucleotide Synthesis Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Solid-phase Oligonucleotide Synthesis Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SOLID-PHASE OLIGONUCLEOTIDE SYNTHESIS MARKET COMPETITIVE LANDSCAPE
3.1 Global Solid-phase Oligonucleotide Synthesis Sales by Manufacturers (2019-2024)
3.2 Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Manufacturers (2019-2024)
3.3 Solid-phase Oligonucleotide Synthesis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Solid-phase Oligonucleotide Synthesis Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Solid-phase Oligonucleotide Synthesis Sales Sites, Area Served, Product Type
3.6 Solid-phase Oligonucleotide Synthesis Market Competitive Situation and Trends
3.6.1 Solid-phase Oligonucleotide Synthesis Market Concentration Rate
3.6.2 Global 5 and 10 Largest Solid-phase Oligonucleotide Synthesis Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 SOLID-PHASE OLIGONUCLEOTIDE SYNTHESIS INDUSTRY CHAIN ANALYSIS
4.1 Solid-phase Oligonucleotide Synthesis Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF SOLID-PHASE OLIGONUCLEOTIDE SYNTHESIS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 SOLID-PHASE OLIGONUCLEOTIDE SYNTHESIS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Solid-phase Oligonucleotide Synthesis Sales Market Share by Type (2019-2024)
6.3 Global Solid-phase Oligonucleotide Synthesis Market Size Market Share by Type (2019-2024)
6.4 Global Solid-phase Oligonucleotide Synthesis Price by Type (2019-2024)
7 SOLID-PHASE OLIGONUCLEOTIDE SYNTHESIS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Solid-phase Oligonucleotide Synthesis Market Sales by Application (2019-2024)
7.3 Global Solid-phase Oligonucleotide Synthesis Market Size (M USD) by Application (2019-2024)
7.4 Global Solid-phase Oligonucleotide Synthesis Sales Growth Rate by Application (2019-2024)
8 SOLID-PHASE OLIGONUCLEOTIDE SYNTHESIS MARKET SEGMENTATION BY REGION
8.1 Global Solid-phase Oligonucleotide Synthesis Sales by Region
8.1.1 Global Solid-phase Oligonucleotide Synthesis Sales by Region
8.1.2 Global Solid-phase Oligonucleotide Synthesis Sales Market Share by Region
8.2 North America
8.2.1 North America Solid-phase Oligonucleotide Synthesis Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Solid-phase Oligonucleotide Synthesis Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Solid-phase Oligonucleotide Synthesis Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Solid-phase Oligonucleotide Synthesis Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Solid-phase Oligonucleotide Synthesis Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Genescript
9.1.1 Genescript Solid-phase Oligonucleotide Synthesis Basic Information
9.1.2 Genescript Solid-phase Oligonucleotide Synthesis Product Overview
9.1.3 Genescript Solid-phase Oligonucleotide Synthesis Product Market Performance
9.1.4 Genescript Business Overview
9.1.5 Genescript Solid-phase Oligonucleotide Synthesis SWOT Analysis
9.1.6 Genescript Recent Developments
9.2 GeneArt (Thermofischer)
9.2.1 GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Basic Information
9.2.2 GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Product Overview
9.2.3 GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Product Market Performance
9.2.4 GeneArt (Thermofischer) Business Overview
9.2.5 GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis SWOT Analysis
9.2.6 GeneArt (Thermofischer) Recent Developments
9.3 Renesas Electronics Corporation
9.3.1 Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Basic Information
9.3.2 Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Product Overview
9.3.3 Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Product Market Performance
9.3.4 Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis SWOT Analysis
9.3.5 Renesas Electronics Corporation Business Overview
9.3.6 Renesas Electronics Corporation Recent Developments
9.4 DNA 2.0 (ATUM)
9.4.1 DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Basic Information
9.4.2 DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Product Overview
9.4.3 DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Product Market Performance
9.4.4 DNA 2.0 (ATUM) Business Overview
9.4.5 DNA 2.0 (ATUM) Recent Developments
9.5 OriGene
9.5.1 OriGene Solid-phase Oligonucleotide Synthesis Basic Information
9.5.2 OriGene Solid-phase Oligonucleotide Synthesis Product Overview
9.5.3 OriGene Solid-phase Oligonucleotide Synthesis Product Market Performance
9.5.4 OriGene Business Overview
9.5.5 OriGene Recent Developments
9.6 BBI
9.6.1 BBI Solid-phase Oligonucleotide Synthesis Basic Information
9.6.2 BBI Solid-phase Oligonucleotide Synthesis Product Overview
9.6.3 BBI Solid-phase Oligonucleotide Synthesis Product Market Performance
9.6.4 BBI Business Overview
9.6.5 BBI Recent Developments
9.7 Genewiz
9.7.1 Genewiz Solid-phase Oligonucleotide Synthesis Basic Information
9.7.2 Genewiz Solid-phase Oligonucleotide Synthesis Product Overview
9.7.3 Genewiz Solid-phase Oligonucleotide Synthesis Product Market Performance
9.7.4 Genewiz Business Overview
9.7.5 Genewiz Recent Developments
9.8 Eurofins Genomics
9.8.1 Eurofins Genomics Solid-phase Oligonucleotide Synthesis Basic Information
9.8.2 Eurofins Genomics Solid-phase Oligonucleotide Synthesis Product Overview
9.8.3 Eurofins Genomics Solid-phase Oligonucleotide Synthesis Product Market Performance
9.8.4 Eurofins Genomics Business Overview
9.8.5 Eurofins Genomics Recent Developments
9.9 Gene Oracle
9.9.1 Gene Oracle Solid-phase Oligonucleotide Synthesis Basic Information
9.9.2 Gene Oracle Solid-phase Oligonucleotide Synthesis Product Overview
9.9.3 Gene Oracle Solid-phase Oligonucleotide Synthesis Product Market Performance
9.9.4 Gene Oracle Business Overview
9.9.5 Gene Oracle Recent Developments
9.10 SBS Genetech
9.10.1 SBS Genetech Solid-phase Oligonucleotide Synthesis Basic Information
9.10.2 SBS Genetech Solid-phase Oligonucleotide Synthesis Product Overview
9.10.3 SBS Genetech Solid-phase Oligonucleotide Synthesis Product Market Performance
9.10.4 SBS Genetech Business Overview
9.10.5 SBS Genetech Recent Developments
9.11 Bio Basic
9.11.1 Bio Basic Solid-phase Oligonucleotide Synthesis Basic Information
9.11.2 Bio Basic Solid-phase Oligonucleotide Synthesis Product Overview
9.11.3 Bio Basic Solid-phase Oligonucleotide Synthesis Product Market Performance
9.11.4 Bio Basic Business Overview
9.11.5 Bio Basic Recent Developments
10 SOLID-PHASE OLIGONUCLEOTIDE SYNTHESIS MARKET FORECAST BY REGION
10.1 Global Solid-phase Oligonucleotide Synthesis Market Size Forecast
10.2 Global Solid-phase Oligonucleotide Synthesis Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Solid-phase Oligonucleotide Synthesis Market Size Forecast by Country
10.2.3 Asia Pacific Solid-phase Oligonucleotide Synthesis Market Size Forecast by Region
10.2.4 South America Solid-phase Oligonucleotide Synthesis Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Solid-phase Oligonucleotide Synthesis by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Solid-phase Oligonucleotide Synthesis Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Solid-phase Oligonucleotide Synthesis by Type (2025-2030)
11.1.2 Global Solid-phase Oligonucleotide Synthesis Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Solid-phase Oligonucleotide Synthesis by Type (2025-2030)
11.2 Global Solid-phase Oligonucleotide Synthesis Market Forecast by Application (2025-2030)
11.2.1 Global Solid-phase Oligonucleotide Synthesis Sales (K Units) Forecast by Application
11.2.2 Global Solid-phase Oligonucleotide Synthesis Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Solid-phase Oligonucleotide Synthesis Market Size Comparison by Region (M USD)
Table 5. Global Solid-phase Oligonucleotide Synthesis Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Solid-phase Oligonucleotide Synthesis Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Solid-phase Oligonucleotide Synthesis Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Solid-phase Oligonucleotide Synthesis Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid-phase Oligonucleotide Synthesis as of 2022)
Table 10. Global Market Solid-phase Oligonucleotide Synthesis Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Solid-phase Oligonucleotide Synthesis Sales Sites and Area Served
Table 12. Manufacturers Solid-phase Oligonucleotide Synthesis Product Type
Table 13. Global Solid-phase Oligonucleotide Synthesis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Solid-phase Oligonucleotide Synthesis
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Solid-phase Oligonucleotide Synthesis Market Challenges
Table 22. Global Solid-phase Oligonucleotide Synthesis Sales by Type (K Units)
Table 23. Global Solid-phase Oligonucleotide Synthesis Market Size by Type (M USD)
Table 24. Global Solid-phase Oligonucleotide Synthesis Sales (K Units) by Type (2019-2024)
Table 25. Global Solid-phase Oligonucleotide Synthesis Sales Market Share by Type (2019-2024)
Table 26. Global Solid-phase Oligonucleotide Synthesis Market Size (M USD) by Type (2019-2024)
Table 27. Global Solid-phase Oligonucleotide Synthesis Market Size Share by Type (2019-2024)
Table 28. Global Solid-phase Oligonucleotide Synthesis Price (USD/Unit) by Type (2019-2024)
Table 29. Global Solid-phase Oligonucleotide Synthesis Sales (K Units) by Application
Table 30. Global Solid-phase Oligonucleotide Synthesis Market Size by Application
Table 31. Global Solid-phase Oligonucleotide Synthesis Sales by Application (2019-2024) & (K Units)
Table 32. Global Solid-phase Oligonucleotide Synthesis Sales Market Share by Application (2019-2024)
Table 33. Global Solid-phase Oligonucleotide Synthesis Sales by Application (2019-2024) & (M USD)
Table 34. Global Solid-phase Oligonucleotide Synthesis Market Share by Application (2019-2024)
Table 35. Global Solid-phase Oligonucleotide Synthesis Sales Growth Rate by Application (2019-2024)
Table 36. Global Solid-phase Oligonucleotide Synthesis Sales by Region (2019-2024) & (K Units)
Table 37. Global Solid-phase Oligonucleotide Synthesis Sales Market Share by Region (2019-2024)
Table 38. North America Solid-phase Oligonucleotide Synthesis Sales by Country (2019-2024) & (K Units)
Table 39. Europe Solid-phase Oligonucleotide Synthesis Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Solid-phase Oligonucleotide Synthesis Sales by Region (2019-2024) & (K Units)
Table 41. South America Solid-phase Oligonucleotide Synthesis Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Solid-phase Oligonucleotide Synthesis Sales by Region (2019-2024) & (K Units)
Table 43. Genescript Solid-phase Oligonucleotide Synthesis Basic Information
Table 44. Genescript Solid-phase Oligonucleotide Synthesis Product Overview
Table 45. Genescript Solid-phase Oligonucleotide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Genescript Business Overview
Table 47. Genescript Solid-phase Oligonucleotide Synthesis SWOT Analysis
Table 48. Genescript Recent Developments
Table 49. GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Basic Information
Table 50. GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Product Overview
Table 51. GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. GeneArt (Thermofischer) Business Overview
Table 53. GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis SWOT Analysis
Table 54. GeneArt (Thermofischer) Recent Developments
Table 55. Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Basic Information
Table 56. Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Product Overview
Table 57. Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis SWOT Analysis
Table 59. Renesas Electronics Corporation Business Overview
Table 60. Renesas Electronics Corporation Recent Developments
Table 61. DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Basic Information
Table 62. DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Product Overview
Table 63. DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. DNA 2.0 (ATUM) Business Overview
Table 65. DNA 2.0 (ATUM) Recent Developments
Table 66. OriGene Solid-phase Oligonucleotide Synthesis Basic Information
Table 67. OriGene Solid-phase Oligonucleotide Synthesis Product Overview
Table 68. OriGene Solid-phase Oligonucleotide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. OriGene Business Overview
Table 70. OriGene Recent Developments
Table 71. BBI Solid-phase Oligonucleotide Synthesis Basic Information
Table 72. BBI Solid-phase Oligonucleotide Synthesis Product Overview
Table 73. BBI Solid-phase Oligonucleotide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. BBI Business Overview
Table 75. BBI Recent Developments
Table 76. Genewiz Solid-phase Oligonucleotide Synthesis Basic Information
Table 77. Genewiz Solid-phase Oligonucleotide Synthesis Product Overview
Table 78. Genewiz Solid-phase Oligonucleotide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Genewiz Business Overview
Table 80. Genewiz Recent Developments
Table 81. Eurofins Genomics Solid-phase Oligonucleotide Synthesis Basic Information
Table 82. Eurofins Genomics Solid-phase Oligonucleotide Synthesis Product Overview
Table 83. Eurofins Genomics Solid-phase Oligonucleotide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Eurofins Genomics Business Overview
Table 85. Eurofins Genomics Recent Developments
Table 86. Gene Oracle Solid-phase Oligonucleotide Synthesis Basic Information
Table 87. Gene Oracle Solid-phase Oligonucleotide Synthesis Product Overview
Table 88. Gene Oracle Solid-phase Oligonucleotide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Gene Oracle Business Overview
Table 90. Gene Oracle Recent Developments
Table 91. SBS Genetech Solid-phase Oligonucleotide Synthesis Basic Information
Table 92. SBS Genetech Solid-phase Oligonucleotide Synthesis Product Overview
Table 93. SBS Genetech Solid-phase Oligonucleotide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. SBS Genetech Business Overview
Table 95. SBS Genetech Recent Developments
Table 96. Bio Basic Solid-phase Oligonucleotide Synthesis Basic Information
Table 97. Bio Basic Solid-phase Oligonucleotide Synthesis Product Overview
Table 98. Bio Basic Solid-phase Oligonucleotide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Bio Basic Business Overview
Table 100. Bio Basic Recent Developments
Table 101. Global Solid-phase Oligonucleotide Synthesis Sales Forecast by Region (2025-2030) & (K Units)
Table 102. Global Solid-phase Oligonucleotide Synthesis Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Solid-phase Oligonucleotide Synthesis Sales Forecast by Country (2025-2030) & (K Units)
Table 104. North America Solid-phase Oligonucleotide Synthesis Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Solid-phase Oligonucleotide Synthesis Sales Forecast by Country (2025-2030) & (K Units)
Table 106. Europe Solid-phase Oligonucleotide Synthesis Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Solid-phase Oligonucleotide Synthesis Sales Forecast by Region (2025-2030) & (K Units)
Table 108. Asia Pacific Solid-phase Oligonucleotide Synthesis Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Solid-phase Oligonucleotide Synthesis Sales Forecast by Country (2025-2030) & (K Units)
Table 110. South America Solid-phase Oligonucleotide Synthesis Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Solid-phase Oligonucleotide Synthesis Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Solid-phase Oligonucleotide Synthesis Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Solid-phase Oligonucleotide Synthesis Sales Forecast by Type (2025-2030) & (K Units)
Table 114. Global Solid-phase Oligonucleotide Synthesis Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Solid-phase Oligonucleotide Synthesis Price Forecast by Type (2025-2030) & (USD/Unit)
Table 116. Global Solid-phase Oligonucleotide Synthesis Sales (K Units) Forecast by Application (2025-2030)
Table 117. Global Solid-phase Oligonucleotide Synthesis Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Solid-phase Oligonucleotide Synthesis Market Size Comparison by Region (M USD)
Table 5. Global Solid-phase Oligonucleotide Synthesis Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Solid-phase Oligonucleotide Synthesis Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Solid-phase Oligonucleotide Synthesis Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Solid-phase Oligonucleotide Synthesis Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid-phase Oligonucleotide Synthesis as of 2022)
Table 10. Global Market Solid-phase Oligonucleotide Synthesis Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Solid-phase Oligonucleotide Synthesis Sales Sites and Area Served
Table 12. Manufacturers Solid-phase Oligonucleotide Synthesis Product Type
Table 13. Global Solid-phase Oligonucleotide Synthesis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Solid-phase Oligonucleotide Synthesis
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Solid-phase Oligonucleotide Synthesis Market Challenges
Table 22. Global Solid-phase Oligonucleotide Synthesis Sales by Type (K Units)
Table 23. Global Solid-phase Oligonucleotide Synthesis Market Size by Type (M USD)
Table 24. Global Solid-phase Oligonucleotide Synthesis Sales (K Units) by Type (2019-2024)
Table 25. Global Solid-phase Oligonucleotide Synthesis Sales Market Share by Type (2019-2024)
Table 26. Global Solid-phase Oligonucleotide Synthesis Market Size (M USD) by Type (2019-2024)
Table 27. Global Solid-phase Oligonucleotide Synthesis Market Size Share by Type (2019-2024)
Table 28. Global Solid-phase Oligonucleotide Synthesis Price (USD/Unit) by Type (2019-2024)
Table 29. Global Solid-phase Oligonucleotide Synthesis Sales (K Units) by Application
Table 30. Global Solid-phase Oligonucleotide Synthesis Market Size by Application
Table 31. Global Solid-phase Oligonucleotide Synthesis Sales by Application (2019-2024) & (K Units)
Table 32. Global Solid-phase Oligonucleotide Synthesis Sales Market Share by Application (2019-2024)
Table 33. Global Solid-phase Oligonucleotide Synthesis Sales by Application (2019-2024) & (M USD)
Table 34. Global Solid-phase Oligonucleotide Synthesis Market Share by Application (2019-2024)
Table 35. Global Solid-phase Oligonucleotide Synthesis Sales Growth Rate by Application (2019-2024)
Table 36. Global Solid-phase Oligonucleotide Synthesis Sales by Region (2019-2024) & (K Units)
Table 37. Global Solid-phase Oligonucleotide Synthesis Sales Market Share by Region (2019-2024)
Table 38. North America Solid-phase Oligonucleotide Synthesis Sales by Country (2019-2024) & (K Units)
Table 39. Europe Solid-phase Oligonucleotide Synthesis Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Solid-phase Oligonucleotide Synthesis Sales by Region (2019-2024) & (K Units)
Table 41. South America Solid-phase Oligonucleotide Synthesis Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Solid-phase Oligonucleotide Synthesis Sales by Region (2019-2024) & (K Units)
Table 43. Genescript Solid-phase Oligonucleotide Synthesis Basic Information
Table 44. Genescript Solid-phase Oligonucleotide Synthesis Product Overview
Table 45. Genescript Solid-phase Oligonucleotide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Genescript Business Overview
Table 47. Genescript Solid-phase Oligonucleotide Synthesis SWOT Analysis
Table 48. Genescript Recent Developments
Table 49. GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Basic Information
Table 50. GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Product Overview
Table 51. GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. GeneArt (Thermofischer) Business Overview
Table 53. GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis SWOT Analysis
Table 54. GeneArt (Thermofischer) Recent Developments
Table 55. Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Basic Information
Table 56. Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Product Overview
Table 57. Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis SWOT Analysis
Table 59. Renesas Electronics Corporation Business Overview
Table 60. Renesas Electronics Corporation Recent Developments
Table 61. DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Basic Information
Table 62. DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Product Overview
Table 63. DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. DNA 2.0 (ATUM) Business Overview
Table 65. DNA 2.0 (ATUM) Recent Developments
Table 66. OriGene Solid-phase Oligonucleotide Synthesis Basic Information
Table 67. OriGene Solid-phase Oligonucleotide Synthesis Product Overview
Table 68. OriGene Solid-phase Oligonucleotide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. OriGene Business Overview
Table 70. OriGene Recent Developments
Table 71. BBI Solid-phase Oligonucleotide Synthesis Basic Information
Table 72. BBI Solid-phase Oligonucleotide Synthesis Product Overview
Table 73. BBI Solid-phase Oligonucleotide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. BBI Business Overview
Table 75. BBI Recent Developments
Table 76. Genewiz Solid-phase Oligonucleotide Synthesis Basic Information
Table 77. Genewiz Solid-phase Oligonucleotide Synthesis Product Overview
Table 78. Genewiz Solid-phase Oligonucleotide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Genewiz Business Overview
Table 80. Genewiz Recent Developments
Table 81. Eurofins Genomics Solid-phase Oligonucleotide Synthesis Basic Information
Table 82. Eurofins Genomics Solid-phase Oligonucleotide Synthesis Product Overview
Table 83. Eurofins Genomics Solid-phase Oligonucleotide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Eurofins Genomics Business Overview
Table 85. Eurofins Genomics Recent Developments
Table 86. Gene Oracle Solid-phase Oligonucleotide Synthesis Basic Information
Table 87. Gene Oracle Solid-phase Oligonucleotide Synthesis Product Overview
Table 88. Gene Oracle Solid-phase Oligonucleotide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Gene Oracle Business Overview
Table 90. Gene Oracle Recent Developments
Table 91. SBS Genetech Solid-phase Oligonucleotide Synthesis Basic Information
Table 92. SBS Genetech Solid-phase Oligonucleotide Synthesis Product Overview
Table 93. SBS Genetech Solid-phase Oligonucleotide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. SBS Genetech Business Overview
Table 95. SBS Genetech Recent Developments
Table 96. Bio Basic Solid-phase Oligonucleotide Synthesis Basic Information
Table 97. Bio Basic Solid-phase Oligonucleotide Synthesis Product Overview
Table 98. Bio Basic Solid-phase Oligonucleotide Synthesis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Bio Basic Business Overview
Table 100. Bio Basic Recent Developments
Table 101. Global Solid-phase Oligonucleotide Synthesis Sales Forecast by Region (2025-2030) & (K Units)
Table 102. Global Solid-phase Oligonucleotide Synthesis Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Solid-phase Oligonucleotide Synthesis Sales Forecast by Country (2025-2030) & (K Units)
Table 104. North America Solid-phase Oligonucleotide Synthesis Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Solid-phase Oligonucleotide Synthesis Sales Forecast by Country (2025-2030) & (K Units)
Table 106. Europe Solid-phase Oligonucleotide Synthesis Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Solid-phase Oligonucleotide Synthesis Sales Forecast by Region (2025-2030) & (K Units)
Table 108. Asia Pacific Solid-phase Oligonucleotide Synthesis Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Solid-phase Oligonucleotide Synthesis Sales Forecast by Country (2025-2030) & (K Units)
Table 110. South America Solid-phase Oligonucleotide Synthesis Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Solid-phase Oligonucleotide Synthesis Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Solid-phase Oligonucleotide Synthesis Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Solid-phase Oligonucleotide Synthesis Sales Forecast by Type (2025-2030) & (K Units)
Table 114. Global Solid-phase Oligonucleotide Synthesis Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Solid-phase Oligonucleotide Synthesis Price Forecast by Type (2025-2030) & (USD/Unit)
Table 116. Global Solid-phase Oligonucleotide Synthesis Sales (K Units) Forecast by Application (2025-2030)
Table 117. Global Solid-phase Oligonucleotide Synthesis Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Solid-phase Oligonucleotide Synthesis
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Solid-phase Oligonucleotide Synthesis Market Size (M USD), 2019-2030
Figure 5. Global Solid-phase Oligonucleotide Synthesis Market Size (M USD) (2019-2030)
Figure 6. Global Solid-phase Oligonucleotide Synthesis Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Solid-phase Oligonucleotide Synthesis Market Size by Country (M USD)
Figure 11. Solid-phase Oligonucleotide Synthesis Sales Share by Manufacturers in 2023
Figure 12. Global Solid-phase Oligonucleotide Synthesis Revenue Share by Manufacturers in 2023
Figure 13. Solid-phase Oligonucleotide Synthesis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Solid-phase Oligonucleotide Synthesis Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Solid-phase Oligonucleotide Synthesis Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Solid-phase Oligonucleotide Synthesis Market Share by Type
Figure 18. Sales Market Share of Solid-phase Oligonucleotide Synthesis by Type (2019-2024)
Figure 19. Sales Market Share of Solid-phase Oligonucleotide Synthesis by Type in 2023
Figure 20. Market Size Share of Solid-phase Oligonucleotide Synthesis by Type (2019-2024)
Figure 21. Market Size Market Share of Solid-phase Oligonucleotide Synthesis by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Solid-phase Oligonucleotide Synthesis Market Share by Application
Figure 24. Global Solid-phase Oligonucleotide Synthesis Sales Market Share by Application (2019-2024)
Figure 25. Global Solid-phase Oligonucleotide Synthesis Sales Market Share by Application in 2023
Figure 26. Global Solid-phase Oligonucleotide Synthesis Market Share by Application (2019-2024)
Figure 27. Global Solid-phase Oligonucleotide Synthesis Market Share by Application in 2023
Figure 28. Global Solid-phase Oligonucleotide Synthesis Sales Growth Rate by Application (2019-2024)
Figure 29. Global Solid-phase Oligonucleotide Synthesis Sales Market Share by Region (2019-2024)
Figure 30. North America Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Solid-phase Oligonucleotide Synthesis Sales Market Share by Country in 2023
Figure 32. U.S. Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Solid-phase Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Solid-phase Oligonucleotide Synthesis Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Solid-phase Oligonucleotide Synthesis Sales Market Share by Country in 2023
Figure 37. Germany Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Solid-phase Oligonucleotide Synthesis Sales Market Share by Region in 2023
Figure 44. China Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (K Units)
Figure 50. South America Solid-phase Oligonucleotide Synthesis Sales Market Share by Country in 2023
Figure 51. Brazil Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Solid-phase Oligonucleotide Synthesis Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Solid-phase Oligonucleotide Synthesis Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Solid-phase Oligonucleotide Synthesis Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Solid-phase Oligonucleotide Synthesis Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Solid-phase Oligonucleotide Synthesis Market Share Forecast by Type (2025-2030)
Figure 65. Global Solid-phase Oligonucleotide Synthesis Sales Forecast by Application (2025-2030)
Figure 66. Global Solid-phase Oligonucleotide Synthesis Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Solid-phase Oligonucleotide Synthesis
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Solid-phase Oligonucleotide Synthesis Market Size (M USD), 2019-2030
Figure 5. Global Solid-phase Oligonucleotide Synthesis Market Size (M USD) (2019-2030)
Figure 6. Global Solid-phase Oligonucleotide Synthesis Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Solid-phase Oligonucleotide Synthesis Market Size by Country (M USD)
Figure 11. Solid-phase Oligonucleotide Synthesis Sales Share by Manufacturers in 2023
Figure 12. Global Solid-phase Oligonucleotide Synthesis Revenue Share by Manufacturers in 2023
Figure 13. Solid-phase Oligonucleotide Synthesis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Solid-phase Oligonucleotide Synthesis Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Solid-phase Oligonucleotide Synthesis Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Solid-phase Oligonucleotide Synthesis Market Share by Type
Figure 18. Sales Market Share of Solid-phase Oligonucleotide Synthesis by Type (2019-2024)
Figure 19. Sales Market Share of Solid-phase Oligonucleotide Synthesis by Type in 2023
Figure 20. Market Size Share of Solid-phase Oligonucleotide Synthesis by Type (2019-2024)
Figure 21. Market Size Market Share of Solid-phase Oligonucleotide Synthesis by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Solid-phase Oligonucleotide Synthesis Market Share by Application
Figure 24. Global Solid-phase Oligonucleotide Synthesis Sales Market Share by Application (2019-2024)
Figure 25. Global Solid-phase Oligonucleotide Synthesis Sales Market Share by Application in 2023
Figure 26. Global Solid-phase Oligonucleotide Synthesis Market Share by Application (2019-2024)
Figure 27. Global Solid-phase Oligonucleotide Synthesis Market Share by Application in 2023
Figure 28. Global Solid-phase Oligonucleotide Synthesis Sales Growth Rate by Application (2019-2024)
Figure 29. Global Solid-phase Oligonucleotide Synthesis Sales Market Share by Region (2019-2024)
Figure 30. North America Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Solid-phase Oligonucleotide Synthesis Sales Market Share by Country in 2023
Figure 32. U.S. Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Solid-phase Oligonucleotide Synthesis Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Solid-phase Oligonucleotide Synthesis Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Solid-phase Oligonucleotide Synthesis Sales Market Share by Country in 2023
Figure 37. Germany Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Solid-phase Oligonucleotide Synthesis Sales Market Share by Region in 2023
Figure 44. China Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (K Units)
Figure 50. South America Solid-phase Oligonucleotide Synthesis Sales Market Share by Country in 2023
Figure 51. Brazil Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Solid-phase Oligonucleotide Synthesis Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Solid-phase Oligonucleotide Synthesis Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Solid-phase Oligonucleotide Synthesis Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Solid-phase Oligonucleotide Synthesis Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Solid-phase Oligonucleotide Synthesis Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Solid-phase Oligonucleotide Synthesis Market Share Forecast by Type (2025-2030)
Figure 65. Global Solid-phase Oligonucleotide Synthesis Sales Forecast by Application (2025-2030)
Figure 66. Global Solid-phase Oligonucleotide Synthesis Market Share Forecast by Application (2025-2030)
